BrainsWay (BWAY) is trading down at $8.48 (-2.86%) on NASDAQ, as of the latest quote. It operates in the Health Care sector.
One firm's current price target on BrainsWay: $19 — 124% above the current $8.48. Each is tracked to its date and scored the same way a member's call is.
1 target, newest first. Open a row for its source and scoring.
Entry price $11.4, the close nearest Oct 30, 2026, when the target was reported; the target is +67% from it.
Horizon H.C. Wainwright set the horizon itself: Oct 2027.
Scoring Open: judged on the close on Oct 30, 2027.
H.C. Wainwright reiterated a Buy rating and $19.00 price target on Brainsway
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
| FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $11.1M | $16.4M | $23.1M | $22.1M | $29.7M | $27.2M | $31.8M | $41.0M |
| Growth (year over year) | — | +47.1% | +40.9% | −4.5% | +34.5% | −8.4% | +17.0% | +29.0% |
| Gross profit | $8.55M | $12.8M | $18.0M | $17.0M | $23.1M | $20.0M | $23.5M | $30.6M |
| Gross margin | 76.7% | 78.1% | 77.8% | 77.1% | 77.7% | 73.8% | 73.9% | 74.6% |
| Operating income | −$6.61M | −$5.11M | −$8.48M | −$4.83M | −$5.00M | −$12.7M | −$4.96M | $1.39M |
| Operating margin | −59.3% | −31.2% | −36.7% | −21.9% | −16.9% | −46.7% | −15.6% | 3.4% |
| Net income | −$7.05M | −$6.48M | −$10.3M | −$5.38M | −$6.46M | −$13.3M | −$4.20M | $2.92M |
| Net margin | −63.3% | −39.5% | −44.7% | −24.4% | −21.8% | −49.1% | −13.2% | 7.1% |
| EPS (diluted) | −$0.48 | −$0.39 | −$0.50 | −$0.24 | −$0.21 | −$0.40 | −$0.13 | $0.05 |
| Balance sheet | ||||||||
| Cash and equivalents | $14.5M | $8.97M | $21.7M | $17.0M | $16.9M | $47.6M | $10.5M | $69.3M |
| Total assets | — | $23.6M | $38.7M | $34.0M | $75.7M | $64.5M | $63.0M | $94.3M |
| Total liabilities | — | $16.6M | $14.5M | $14.4M | $18.4M | $19.1M | $21.4M | $32.0M |
| Shareholders' equity | $12.7M | $6.95M | $24.2M | $19.6M | $57.3M | $45.4M | $41.6M | $62.3M |
| Cash flow | ||||||||
| Operating cash flow | −$3.47M | −$3.77M | −$7.24M | −$1.44M | $884.0K | −$9.76M | $1.28M | $10.3M |
| Capital expenditure | $985.0K | $1.97M | $3.31M | $2.47M | $2.24M | — | — | — |
| Free cash flow | −$4.45M | −$5.75M | −$10.6M | −$3.91M | −$1.35M | — | — | — |
| Q3 FY19Sep 2019 | Q4 FY19†Dec 2019 | Q3 FY20Sep 2020 | Q4 FY20†Dec 2020 | |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | — | $6.29M | — | $7.07M |
| Growth (year over year) | — | — | — | +12.3% |
| Gross profit | — | $4.85M | — | $5.50M |
| Gross margin | — | 77.1% | — | 77.8% |
| Operating income | — | −$15.0M | — | −$9.25M |
| Operating margin | — | −237.8% | — | −130.9% |
| Net income | — | −$2.32M | — | −$406.0K |
| Net margin | — | −36.8% | — | −5.7% |
| EPS (diluted) | — | −$0.10 | — | −$0.02 |
| Balance sheet | ||||
| Cash and equivalents | $21.7M | $21.7M | $15.8M | $17.0M |
| Total assets | $38.7M | $38.7M | $34.4M | $34.0M |
| Total liabilities | $14.5M | $14.5M | $14.5M | $14.4M |
| Shareholders' equity | $24.2M | $24.2M | $19.9M | $19.6M |
| Cash flow | ||||
| Operating cash flow | — | −$1.23M | — | $1.64M |
| Capital expenditure | — | $338.0K | — | −$85.0K |
| Free cash flow | — | −$1.57M | — | $1.73M |
From BrainsWay's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Read at Investing.com ↗ Link to this story